Novel peripheral blood mononuclear cell mRNA signature for IFN-beta therapy responsiveness prediction in multiple sclerosis

Novel peripheral blood mononuclear cell mRNA signature for IFN-beta therapy responsiveness prediction in multiple sclerosis

Interferon-beta (IFN-[Formula: see text]) is one of the classical drugs for immunomodulatory therapy in relapsing-remitting multiple sclerosis (RRMS) patients, but the drug responsiveness of different patients varies. Currently, there is no valid model to predict IFN-[Formula: see text] responsivene...

Full description

Bibliographic Details
Main Authors: Yang Xue, Pengqi Yin, Hongping Chen, Guozhong Li, Di Zhong
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Autoimmunity
Subjects:
Multiple sclerosis
IFN- therapy
drug responsiveness
prognostic model construction
survival analysis
Online Access:https://www.tandfonline.com/doi/10.1080/08916934.2024.2332340

Internet

https://www.tandfonline.com/doi/10.1080/08916934.2024.2332340

Similar Items